ScholarLens Back to search
1990•PubMedRequires access

[Fetal hepatocellular suspension transfusion in the treatment of chronic active hepatitis B].

Zhu Rp, X Y Lin, Wang Jt

Open publisher page 2 citations

Abstract

Using the paired method and the same observation standard, 35 pairs of patients (70 patients) suffering from chronic active hepatitis B were treated with FHST or glucose in 5 hospitals. After three months of treatment a significant decrease in ALT, TTT and a significant increase in PTA were observed in FHST group as compared with the control group (p less than 0.05-0.01). There was no significant change in HBVM in both groups. No side effect was observed during the period of treatment.

About this research paper

What this paper is about

Using the paired method and the same observation standard, 35 pairs of patients (70 patients) suffering from chronic active hepatitis B were treated with FHST or glucose in 5 hospitals. After three months of treatment a significant decrease in ALT, TTT and a significant increase in PTA were observed in FHST group as compared with the control group (p less than 0.05-0.01). There was no significant change in HBVM in both groups. No side effect was observed during the period of treatment.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Using the paired method and the same observation standard, 35 pairs of patients (70 patients) suffering from chronic active hepatitis B were treated with FHST or glucose in 5 hospitals. After three months of treatment a significant decrease in ALT, TTT and a significant increase in PTA were observed in FHST group as compared with the control group (p less than 0.05-0.01). There was no significant change in HBVM in both groups. No side effect was observed during the period of treatment.

Key concepts: Medicine, Chronic hepatitis, Fetus, Hepatitis, Internal medicine, Gastroenterology, Surgery, Pregnancy

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
[Fetal hepatocellular suspension transfusion in the treatment of chronic active hepatitis B]. — Research Paper | ScholarLens